C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation

Karin Heidenreich, Deepti Goel, P. S. Priyamvada, Sagar Kulkarni, Vipul Chakurkar, Dinesh Khullar, Ravi Singh, Charan Bale, Peter F. Zipfel

Open source

DOI
10.3389/fneph.2024.1460146
Published
2024-10-29
Container
Frontiers in Nephrology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneph.2024.1460146,
  title = {C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation},
  author = {Karin Heidenreich and Deepti Goel and P. S. Priyamvada and Sagar Kulkarni and Vipul Chakurkar and Dinesh Khullar and Ravi Singh and Charan Bale and Peter F. Zipfel},
  year = {2024},
  journal = {Frontiers in Nephrology},
  doi = {10.3389/fneph.2024.1460146},
  url = {https://doi.org/10.3389/fneph.2024.1460146}
}

RIS

TY  - JOUR
TI  - C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation
AU  - Karin Heidenreich
AU  - Deepti Goel
AU  - P. S. Priyamvada
AU  - Sagar Kulkarni
AU  - Vipul Chakurkar
AU  - Dinesh Khullar
AU  - Ravi Singh
AU  - Charan Bale
AU  - Peter F. Zipfel
PY  - 2024
JO  - Frontiers in Nephrology
DO  - 10.3389/fneph.2024.1460146
UR  - https://doi.org/10.3389/fneph.2024.1460146
ER  - 

APA

Heidenreich, K., Goel, D., Priyamvada, P. S., Kulkarni, S., Chakurkar, V., Khullar, D., Singh, R., Bale, C., & Zipfel, P. F. (2024). C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation. Frontiers in Nephrology. https://doi.org/10.3389/fneph.2024.1460146

Source records